The latest biotech news

News and Trends 29 Oct 2020

Universal Flu Vaccines Yield Second Clinical Failure This Year

In a blow to hopes for better protection from seasonal flu, last week’s phase III failure of BiondVax’s universal flu vaccine follows the phase II flop of Vaccitech’s flu vaccine in January. Last week proved a major setback for the Israeli biotech BiondVax. The company’s vaccine — designed to protect against multiple strains of flu […]

October 29, 2020 - 5 minutesmins - By Jonathan Smith

News and Trends 15 Oct 2020

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest company to tackle the rare condition neuromyelitis optica, for which three therapies have been approved in less than a year. Neuromyelitis optica spectrum disorders, previously also known as Devic disease, affect up to 2 in 100,000 people around the world. […]

October 15, 2020 - 3 minutesmins - By Helen Albert

News and Trends 14 Oct 2020

Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions

The Swedish firm Cartana and US-based ReadCoor have recently been snapped up by the US giant 10x Genomics to get hold of their spatial transcriptomics technology. What impact will these acquisitions have on the burgeoning field going forward? Last week, 10x Genomics took over ReadCoor for a smooth €298M ($350M). This followed the acquisition of […]

October 14, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 9 Oct 2020

2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers

The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing tool, with the Nobel Prize in Chemistry awarded to two of its leading developers this week. The Prize in Chemistry went to Emmanuelle Charpentier, Director at the Max Planck Institute for Infection Biology in Berlin, and Jennifer Doudna, a Professor […]

October 9, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 7 Oct 2020

Investment Is Pouring Into Neuromodulation Treatments

The last month has seen several big investments in European neuromodulation and neurostimulation companies, which aim to treat neurological conditions by zapping nerve cells. What’s the reason for this funding peak? Last week, the Italian firm WISE announced the closing of a €15M Series C round to fund the development of a device that blocks […]

October 7, 2020 - 6 minutesmins - By Helen Albert

News and Trends 5 Oct 2020

Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection

The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the FDA’s rejection in August. What does this signal for Galapagos, Gilead, and other biotechs working in inflammatory disease? For Galapagos and Gilead, it’s been a rollercoaster few months. In August, the FDA decided against approving their drug filgotinib for treating […]

October 5, 2020 - 5 minutesmins - By Jonathan Smith

News and Trends 2 Oct 2020

Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers

The Netherlands-based food technology company Mosa Meat has raised €62M in a Series B round that will be used to bring its cultured beef products a step closer to the market. The funding round was led by the Luxembourg firm Blue Horizon Ventures in collaboration with the Bell Food Group, M Ventures, and others. Of […]

October 2, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 1 Oct 2020

Medicxi to Shake up the Biotech VC Investment Model with €200M Fund

UK-based investment firm Medicxi aims to attract more investors to the life sciences with a new fund that lets them cash in on their investments earlier than conventional funds. Last week, Medicxi closed a €200M fund called Medicxi Secondary 1 (MS1), which was co-led by the UK’s Pantheon and Switzerland’s LGT Capital Partners. The aim […]

October 1, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 25 Sep 2020

Roche Confirms Pharma Appetite for Inflammatory Disease Treatments

Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory disease drugs. How could other companies in the field benefit from this takeover? The inflammation process is essential for our survival, as it helps the body to clear up damage after injury. However, uncontrolled inflammation can also harm us, causing […]

September 25, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 17 Sep 2020

3D Bioprinting Gains a Foothold in Biomedicine

3D printing has revolutionized manufacturing by reducing costs and giving designers and engineers immense flexibility. Could 3D bioprinting do the same for biotechnology? The 3D bioprinting field is still quite young, but it is developing rapidly. In fact, the 3D bioprinting market is expected to grow from €700M ($820M) in 2019 to a massive €4B […]

September 17, 2020 - 5 minutesmins - By Kostas Vavitsas

News and Trends 14 Sep 2020

T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors

The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a spectacularly large Series A round in Europe this year. The Series A round was co-led by the VC firms EcoR1 Capital, Syncona, and Jeito Capital. Neogene Therapeutics will use part of the €93M proceeds to advance its T-cell therapy immuno-oncology […]

September 14, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Sep 2020

The Funding Flow Between European and US Life Sciences

Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the records of past investments can be essential for making sense of the future and getting closer to discovering what’s next for the life sciences industry. Exploring the differences between the two major groups of life sciences investors and the funding […]

September 14, 2020 - 11 minutesmins - By External Contributor

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Universal Flu Vaccines Yield Second Clinical Failure This Year

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions

2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers

Investment Is Pouring Into Neuromodulation Treatments

Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection

Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers

Medicxi to Shake up the Biotech VC Investment Model with €200M Fund

Roche Confirms Pharma Appetite for Inflammatory Disease Treatments

3D Bioprinting Gains a Foothold in Biomedicine

T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors

The Funding Flow Between European and US Life Sciences

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!